Ladenburg Thalmann Financial Services’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$83K Buy
+3,325
New +$67.4K ﹤0.01% 3165
2019
Q3
Sell
-520
Closed -$12K 5547
2019
Q2
$12K Sell
520
-135
-21% -$3.64K ﹤0.01% 4360
2019
Q1
$21K Buy
655
+391
+148% +$12.1K ﹤0.01% 3975
2018
Q4
$7K Buy
264
+140
+113% +$4.1K ﹤0.01% 4477
2018
Q3
$4K Buy
+124
New +$3.73K ﹤0.01% 4723
2016
Q2
Sell
-895
Closed -$17K 4877
2016
Q1
$17K Buy
895
+102
+13% +$1.85K ﹤0.01% 3381
2015
Q4
$18K Buy
793
+770
+3,348% +$15.2K ﹤0.01% 3308
2015
Q3
$0 Buy
+23
New +$635 ﹤0.01% 4782

Other funds holding XENT

Ladenburg Thalmann Financial Services's XENT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services opened a new position in Intersect ENT, Inc (XENT) in Q4 2019: 3,325 shares worth $83K. The stake represents ﹤0.01% of the portfolio and ranks #3165 among its holdings. This is a return to the name: Ladenburg Thalmann Financial Services previously reported a position in XENT as recently as Q2 2019.

Ladenburg Thalmann Financial Services first reported a position in XENT in Q3 2015 and has held it in 8 quarters since. 120 funds tracked by Wall St. Rank hold XENT as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 3,325 shares of Intersect ENT, Inc worth $83K as of Q4 2019.
  • Intersect ENT, Inc was a new Ladenburg Thalmann Financial Services position in Q4 2019.
  • Intersect ENT, Inc made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3165 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Intersect ENT, Inc in Q3 2015 and has held it in 8 quarters since.
  • 120 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.